We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+22.12%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.31B
AUM Growth
+$60.5M
Cap. Flow
-$126M
Cap. Flow %
-9.59%
Top 10 Hldgs %
52.31%
Holding
44
New
8
Increased
6
Reduced
15
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 48.96%
2 Consumer Discretionary 17.87%
3 Technology 16.11%
4 Communication Services 5.21%
5 Financials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVN icon
26
LivaNova
LIVN
$4.42B
$14.3M 1.09%
+216,515
New +$12M
LBRDA icon
27
Liberty Broadband Class A
LBRDA
$4.9B
$13.8M 1.06%
87,833
ZBH icon
28
Zimmer Biomet
ZBH
$18.1B
$13.7M 1.05%
+91,742
New +$13M
TGTX icon
29
TG Therapeutics
TGTX
$8.01B
$13.4M 1.02%
256,897
FCNCA icon
30
First Citizens BancShares
FCNCA
$24.8B
$11.5M 0.88%
+20,000
New +$10.1M
AVAN.U
31
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
$10.8M 0.83%
+1,000,000
New +$10.2M
DXCM icon
32
DexCom
DXCM
$32.1B
$9.66M 0.74%
104,496
-20,612
-16% -$1.84M
ACACU
33
DELISTED
Acies Acquisition Corp Unit
ACACU
$9.65M 0.74%
+900,000
New +$9.16M
CHFW.U
34
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$7.33M 0.56%
+700,000
New +$7.15M
QTRX icon
35
Quanterix
QTRX
$164M
$6.31M 0.48%
135,685
-72,500
-35% -$3.16M
LH icon
36
Labcorp
LH
$25.5B
$6.24M 0.48%
35,677
-63,744
-64% -$11M
DMTK
37
DELISTED
DermTech, Inc. Common Stock
DMTK
$5.85M 0.45%
+180,304
New +$2.56M
ARNA
38
DELISTED
Arena Pharmaceuticals Inc
ARNA
$5.28M 0.4%
68,764
-293,718
-81% -$22M
ALEC icon
39
Alector
ALEC
$170M
$3.47M 0.26%
229,117
CNC icon
40
Centene
CNC
$30.6B
-799,880
Closed -$46.7M
INSP icon
41
Inspire Medical Systems
INSP
$1.45B
-105,411
Closed -$13.6M
MGM icon
42
MGM Resorts International
MGM
$11.4B
-957,528
Closed -$20.8M
DRNA
43
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-503,012
Closed -$9.05M
BMY.RT
44
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-4,427,269
Closed -$9.96M

Similar funds

Bridger Management's Q4 2020 Portfolio in Review

As of Q4 2020, Bridger Management held 44 positions worth $1.31B, up 4.8% from $1.25B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Bridger Management withdrew a net $126M in Q4 2020, closing 5 positions and reducing 15 holdings. Its most notable exit was Centene, an estimated $46.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 55% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Bridger Management opened a new position in SQZ Biotechnologies Company worth $23.4M.

  • Bridger Management's largest Q4 2020 buy was SQZ Biotechnologies Company: 807,827 shares worth $23.4M.
  • Bridger Management added most to Ross Stores in Q4 2020, an estimated $11.7M increase.
  • Bridger Management's biggest Q4 2020 reduction was Natera, cutting an estimated $51.1M.
  • Bridger Management fully exited Centene in Q4 2020, selling an estimated $46.7M.
  • Bridger Management's ten largest holdings make up 52% of its $1.31B portfolio in Q4 2020.
  • Bridger Management opened 8 new positions and closed 5 in Q4 2020.
  • Bridger Management's portfolio value rose 4.8% quarter-over-quarter to $1.31B.

Based on Bridger Management's 13F filing for Q4 2020, filed 16 Feb 2021.